ZyVersa Therapeutics (ZVSA) Short Interest Ratio & Short Volume → 'The Biggest Drug Ever' Is Coming (From Behind the Markets) (Ad) Free ZVSA Stock Alerts $4.94 -0.35 (-6.62%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media ZyVersa Therapeutics Short Interest DataCurrent Short Volume15,600 sharesPrevious Short Volume460,800 sharesChange Vs. Previous Month-96.61%Dollar Volume Sold Short$82,524.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 30, 2024Outstanding Shares760,000 sharesFloat Size750,600 sharesShort Percent of Float2.08%Today's Trading Volume58,445 sharesAverage Trading Volume301,961 sharesToday's Volume Vs. Average19% Short Selling ZyVersa Therapeutics ? Sign up to receive the latest short interest report for ZyVersa Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatZVSA Short Interest Over TimeZVSA Days to Cover Over TimeZVSA Percentage of Float Shorted Over Time Ad Chaikin AnalyticsWall Street legend who predicted 2021 tech crash issues new warningPeople around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch his stock warning right here, 100% free of charge ZyVersa Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202415,600 shares $82,524.00 -96.6%2.1%0 $5.29 4/15/2024460,800 shares $292,838.40 -20.6%6.1%0.2 $0.64 3/31/2024580,600 shares $435,450.00 -10.1%8.1%0.2 $0.75 3/15/2024646,000 shares $504,203.00 -45.7%16.9%0.2 $0.78 2/29/20241,190,000 shares $1.31 million +619.5%74.4%0.4 $1.10 2/15/2024165,400 shares $95,402.72 -14.5%10.3%0.1 $0.58 Get the Latest News and Ratings for ZVSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024193,500 shares $110,314.35 +545.0%1.5%0.2 $0.57 1/15/202430,000 shares $22,608.00 -51.6%0.2%0 $0.75 12/31/202362,000 shares $55,800.00 +38.1%0.5%0.1 $0.90 12/15/202344,900 shares $34,797.50 +152.3%0.4%0.1 $0.78 11/30/202317,800 shares $40,495.00 -99.2%0.1%0 $2.28 11/15/20232,300,000 shares $191,130.00 +25.7%18.3%0.3 $0.08 10/31/20231,830,000 shares $150,060.00 -26.8%14.6%0.3 $0.08 10/15/20232,500,000 shares $324,750.00 +86.6%19.9%0.5 $0.13 9/30/20231,340,000 shares $173,530.00 -63.1%10.7%0.3 $0.13 9/15/20233,630,000 shares $540,870.00 +1,168.8%28.9%0.8 $0.15 8/31/2023286,100 shares $40,683.42 -9.2%2.3%0.1 $0.14 8/15/2023315,100 shares $50,416.00 -52.4%2.5%0.2 $0.16 7/31/2023662,600 shares $114,298.50 -43.9%5.3%0.3 $0.17 7/15/20231,180,000 shares $293,466.00 +148.0%N/A0.4 $0.25 6/30/2023475,900 shares $116,833.45 -37.4%N/A0.2 $0.25 6/15/2023760,400 shares $250,932.00 +6.7%N/A0.4 $0.33 5/31/2023712,400 shares $260,738.40 +178.9%N/A0.4 $0.37 5/15/2023255,400 shares $110,409.42 No ChangeN/A0.2 $0.43 ZVSA Short Interest - Frequently Asked Questions What is ZyVersa Therapeutics' current short interest? Short interest is the volume of ZyVersa Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 15,600 shares of ZVSA short. 2.08% of ZyVersa Therapeutics' shares are currently sold short. Learn More on ZyVersa Therapeutics' current short interest. What is a good short interest percentage for ZyVersa Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.08% of ZyVersa Therapeutics' floating shares are currently sold short. Is ZyVersa Therapeutics' short interest increasing or decreasing? ZyVersa Therapeutics saw a decline in short interest in April. As of April 30th, there was short interest totaling 15,600 shares, a decline of 96.6% from the previous total of 460,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ZyVersa Therapeutics' float size? ZyVersa Therapeutics currently has issued a total of 760,000 shares. Some of ZyVersa Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ZyVersa Therapeutics currently has a public float of 750,600 shares. How does ZyVersa Therapeutics' short interest compare to its competitors? 2.08% of ZyVersa Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ZyVersa Therapeutics: Seelos Therapeutics, Inc. (6.86%), Kazia Therapeutics Limited (0.53%), NexImmune, Inc. (0.55%), Petros Pharmaceuticals, Inc. (3.25%), Bright Minds Biosciences Inc. (2.57%), Lipella Pharmaceuticals Inc. (1.05%), Synaptogenix, Inc. (2.88%), Genprex, Inc. (2.46%), GT Biopharma, Inc. (0.48%), First Wave BioPharma, Inc. (2.39%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short ZyVersa Therapeutics stock? Short selling ZVSA is an investing strategy that aims to generate trading profit from ZyVersa Therapeutics as its price is falling. ZVSA shares are trading down $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ZyVersa Therapeutics? A short squeeze for ZyVersa Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ZVSA, which in turn drives the price of the stock up even further. How often is ZyVersa Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZVSA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Seelos Therapeutics Short Interest Kazia Therapeutics Short Interest NexImmune Short Interest Petros Pharmaceuticals Short Interest Bright Minds Biosciences Short Interest Lipella Pharmaceuticals Short Interest Synaptogenix Short Interest Genprex Short Interest GT Biopharma Short Interest First Wave BioPharma Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ZVSA) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressCharles Payne Demystifies OptionsUnstoppable Prosperity